Which hedge funds own AMLX? AMYLYX PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in AMLX (AMYLYX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $25.2m in total. The largest holder by portfolio weight is Woodline Partners at 0.0% of its book. 1 manager opened a new position this quarter: Brevan Howard Capital Management.
6tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold AMLX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.0% | $15.2m | 846,387 | 0% | held |
| Falcon Edge Capital | Q2 2026 | 0.0% | $2.8m | 155,422 | 9% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $208.5k | 11,611 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $636.0k | 35,410 | 13% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $3.1m | 174,285 | 135% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $3.2m | 178,686 | -57% | reduced |
How has hedge fund ownership of AMLX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $25.2m |
| Q1 2026 | 6 | $22.4m |
| Q4 2025 | 5 | $20.7m |
| Q3 2025 | 4 | $54.1m |
| Q2 2025 | 5 | $41.2m |
| Q1 2025 | 5 | $11.5m |
| Q4 2024 | 3 | $2.4m |
| Q3 2024 | 4 | $6.8m |
| Q2 2024 | 3 | $4.7m |
| Q1 2024 | 5 | $7.3m |
| Q4 2023 | 7 | $106.0m |
| Q3 2023 | 8 | $122.6m |
| Q2 2023 | 6 | $122.6m |
| Q1 2023 | 7 | $164.9m |
| Q4 2022 | 7 | $308.2m |
| Q3 2022 | 5 | $224.5m |
Counts every tracked manager that disclosed AMLX in that quarter's filing, including managers that have since stopped filing.